Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity.Obje...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Colombia Médica
Autores principales: Adriana Linares Ballesteros, Roy Sanguino Lobo, Juan Camilo Villada Valencia, Oscar Arévalo Leal, Diana Constanza Plazas Hernández, Nelson Aponte Barrios, Iván Perdomo Ramírez
Formato: Artigo
Lenguaje:Inglês
Publicado: Universidad del Valle 2021
Materias:
Medicina
Child
leukemia
drug therapy
anthracyclines
echocardiography
Acceso en línea:https://www.redalyc.org/articulo.oa?id=28366572004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Cargando...

Ejemplares similares